Get started
Author

Catherine M. Wiscount

Observed names: C. M. WISCOUNT, C. M. Wiscount, Catherine Wiscount
OpenAlex ID: A5035951192
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors
1991 · Terry A. Lyle, Catherine M. Wiscount, et al. · Journal of Medicinal Chemistry · 97
Synthesis of a Series of 4-(Arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
1994 · Thomas J. Tucker, Terry A. Lyle, et al. · Journal of Medicinal Chemistry · 72
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors
2017 · Christopher J. Bungard, Peter D. Williams, et al. · ACS Medicinal Chemistry Letters · 45
Multi-lab study on the pure-gas permeation of commercial polysulfone (PSf) membranes: Measurement standards and best practices
2022 · Katherine Mizrahi Rodriguez, Wan-Ni Wu, et al. · Journal of Membrane Science · 41
Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability
2006 · Donnette D. Staas, Kelly L. Savage, et al. · Bioorganic & Medicinal Chemistry · 37
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group
2016 · Christopher J. Bungard, Peter D. Williams, et al. · ACS Medicinal Chemistry Letters · 26
N-Arylalkyl Pseudopeptide Inhibitors of Farnesyltransferase
1998 · S. Jane deSolms, Elizabeth A. Giuliani, et al. · Journal of Medicinal Chemistry · 23
10-Hydroxy-7,8-dihydropyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: Potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants
2008 · Catherine M. Wiscount, Peter D. Williams, et al. · Bioorganic & Medicinal Chemistry Letters · 19
ChemInform Abstract: Synthesis of a Series of 4‐(Arylethynyl)‐6‐chloro‐4‐cyclopropyl‐3,4‐ dihydroquinazolin‐2(1H)‐ones as Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.
1994 · T. J. TUCKER, T. A. LYLE, et al. · ChemInform · 5
A Priori Prediction of Activity for HIV-1 Protease Inhibitors Employing Energy Minimization in the Active Site
1996 · M. Katharine Holloway, Jenny M. Wai, et al. · Journal of Medicinal Chemistry · 2
PDF
Structure-activity studies and antiviral properties of hydroxyethylene transition state inhibitors of HIV-1 protease
1992 · L. S. Payne, S. D. Young, et al. · Springer eBooks
Works count: 11
Citation count: 367
H-index: 8
I10-index: 8
Year
Topic
Type